Expression of fluorescent proteins in bifidobacteria for analysis of host-microbe interactions

Applied and Environmental Microbiology

Volumn 80, Issue 9, 2014, Pages 2842-2850

  Grimm, Verena ^a   Gleinser, Marita ^a   Neu, Caroline ^a   Zhurina, Daria ^a   Riedel, Christian U ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CLONING; FLUORESCENCE; PROTEINS; TOOLS;

BIFIDOBACTERIUM BIFIDUM; CYAN FLUORESCENT PROTEIN; FLUORESCENT PROTEINS (FPS); GREEN FLUORESCENT PROTEIN; ORAL ADMINISTRATION; PROMOTER ACTIVITIES; TRANSCRIPTIONAL ACTIVITY; YELLOW FLUORESCENT PROTEINS;

BACTERIA;

PHOTOPROTEIN;

ANIMAL; BIFIDOBACTERIALES INFECTION; BIFIDOBACTERIUM; C57BL MOUSE; CELL TRACKING; EVALUATION STUDY; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY; PROCEDURES; PROMOTER REGION;

ANIMALS; BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM; CELL TRACKING; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; LUMINESCENT PROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC;

EID: 84898664324     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.04261-13     Document Type: Article

References (69)

1. Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, Chater KF, van Sinderen D. 2007. Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol. Mol. Biol. Rev. 71:495-548. http://dx.doi.org/10.1128/MMBR.00005-07.
2. Lee J-H, O'Sullivan DJ. 2010. Genomic insights into bifidobacteria. Microbiol. Mol. Biol. Rev. 74:378-416. http://dx.doi.org/10.1128/MMBR.00004-10.
3. Leahy SC, Higgins DG, Fitzgerald GF, van Sinderen D. 2005. Getting better with bifidobacteria. J. Appl. Microbiol. 98:1303-1315. http://dx.doi.org/10.1111/j.1365-2672.2005.02600.x.
4. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C. 2005. Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22:495-512. http://dx.doi.org/10.1111/j.1365-2036.2005.02615.x.
5. Riedel C-U, Foata F, Philippe D, Adolfsson O, Eikmanns B-J, Blum S. 2006. Anti-inflammatory effects of bifidobacteria by inhibition of LPSinduced NF-kappaB activation. World J. Gastroenterol. 12:3729-3735. http://www.wjgnet.com/1007-9327/full/v12/i23/3729.htm.
6. Preising J, Philippe D, Gleinser M, Wei H, Blum S, Eikmanns BJ, Niess J-H, Riedel CU. 2010. Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl. Environ. Microbiol. 76:3048-3051. http://dx.doi.org/10.1128/AEM.03127-09.
7. Philippe D, Heupel E, Blum-Sperisen S, Riedel CU. 2011. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis. Int. J. Food Microbiol. 149:45-49. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.12.020.
8. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, Khlebnikov A, van Hylckama Vlieg JET, Punit S, Glickman JN, Onderdonk A, Glimcher LH, Garrett WS. 2010. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. U. S. A. 107:18132-18137. http://dx.doi.org/10.1073/pnas.1011737107.
9. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 174:3237-3246.
10. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K. 2012. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 8:e1002714. http://dx.doi.org/10.1371/journal.ppat.1002714.
11. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543-547. http://dx.doi.org/10.1038/nature09646.
12. Fanning S, Hall LJ, Cronin M, Zomer A, Macsharry J, Goulding D, O'Connell Motherway M, Shanahan F, Nally K, Dougan G, van Sinderen D. 2012. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl. Acad. Sci. U. S. A. 109:2108-2113. http://dx.doi.org/10.1073/pnas.1115621109.
13. Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y. 2004. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72: 2240-2247. http://dx.doi.org/10.1128/IAI.72.4.2240-2247.2004.
14. Westermann C, Zhurina DS, Baur A, Shang W, Yuan J, Riedel CU. 2012. Exploring the genome sequence of Bifidobacterium bifidum S17 for potential players in host-microbe interactions. Symbiosis 58:191-200. http://dx.doi.org/10.1007/s13199-012-0205-z.
15. Foroni E, Serafini F, Amidani D, Turroni F, He F, Bottacini F, O'Connell Motherway M, Viappiani A, Zhang Z, Rivetti C, van Sinderen D, Ventura M. 2011. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microb. Cell Fact. 10(Suppl 1):S16. http://dx.doi.org/10.1186/1475-2859-10-S1-S16.
16. Turroni F, Serafini F, Foroni E, Duranti S, O'Connell Motherway M, Taverniti V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sánchez B, Santoni A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza P, Bolchi A, Guglielmetti S, van Sinderen D, Ventura M. 2013. Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc. Natl. Acad. Sci. U. S. A. 110:11151-11156. http://dx.doi.org/10.1073/pnas.1303897110.
17. O'Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, O'Brien F, Flynn K, Casey PG, Munoz JAM, Kearney B, Houston AM, O'Mahony C, Higgins DG, Shanahan F, Palva A, de Vos WM, Fitzgerald GF, Ventura M, O'Toole PW, van Sinderen D. 2011. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved hostcolonization factor. Proc. Natl. Acad. Sci. U. S. A. 108:11217-11222. http://dx.doi.org/10.1073/pnas.1105380108.
18. Anonymous. 2013. Culture shock. Nature 493:133-134. http://dx.doi.org/10.1038/493133b.
19. Brancaccio VF, Zhurina DS, Riedel CU. 2013. Tough nuts to crack: site-directed mutagenesis of bifidobacteria remains a challenge. Bioengineered 4:197-202. http://dx.doi.org/10.4161/bioe.23381.
20. Ruiz L, Motherway MO, Lanigan N, van Sinderen D. 2013. Transposon mutagenesis in Bifidobacterium breve: construction and characterization of a Tn5 transposon mutant library for Bifidobacterium breve UCC2003. PLoS One 8:e64699. http://dx.doi.org/10.1371/journal.pone.0064699.
21. Sun Z, Baur A, Zhurina D, Yuan J, Riedel CU. 2012. Accessing the inaccessible: molecular tools for bifidobacteria. Appl. Environ. Microbiol. 78:5035-5042. http://dx.doi.org/10.1128/AEM.00551-12.
22. Cronin M, Sleator RD, Hill C, Fitzgerald GF, van Sinderen D. 2008. Development of a luciferase-based reporter system to monitor Bifidobacterium breve UCC2003 persistence in mice. BMC Microbiol. 8:161. http://dx.doi.org/10.1186/1471-2180-8-161.
23. Cronin M, Morrissey D, Rajendran S, El Mashad SM, van Sinderen D, O'Sullivan GC, Tangney M. 2010. Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. Mol. Ther. J. Am. Soc. Gene Ther. 18:1397-1407. http://dx.doi.org/10.1038/mt.2010.59.
24. Cronin M, Akin AR, Collins SA, Meganck J, Kim J-B, Baban CK, Joyce SA, van Dam GM, Zhang N, van Sinderen D, O'Sullivan GC, Kasahara N, Gahan CG, Francis KP, Tangney M. 2012. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS One 7:e30940. http://dx.doi.org/10.1371/journal.pone.0030940.
25. Shimomura O, Johnson FH, Saiga Y. 1962. Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J. Cell. Comp. Physiol. 59:223-239. http://dx.doi.org/10.1002/jcp.1030590302.
26. Zhang J, Campbell RE, Ting AY, Tsien RY. 2002. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 3:906-918. http://dx.doi.org/10.1038/nrm976.
27. Shaner NC, Steinbach PA, Tsien RY. 2005. A guide to choosing fluorescent proteins. Nat. Methods 2:905-909. http://dx.doi.org/10.1038/nmeth819.
28. Giepmans BNG, Adams SR, Ellisman MH, Tsien RY. 2006. The fluorescent toolbox for assessing protein location and function. Science 312: 217-224. http://dx.doi.org/10.1126/science.1124618.
29. Lissemore JL, Jankowski JT, Thomas CB, Mascotti DP, de Haseth PL.2000. Green fluorescent protein as a quantitative reporter of relative promoter activity in E. coli. Biotechniques 28:82-89.
30. Southward CM, Surette MG. 2002. The dynamic microbe: green fluorescent protein brings bacteria to light. Mol. Microbiol. 45:1191-1196. http://dx.doi.org/10.1046/j.1365-2958.2002.03089.x.
31. Bongaerts RJM, Hautefort I, Sidebotham JM, Hinton JCD. 2002. Green fluorescent protein as a marker for conditional gene expression in bacterial cells. Methods Enzymol. 358:43-66. http://dx.doi.org/10.1016/S0076-6879(02)58080-0.
32. Larrainzar E, O'Gara F, Morrissey JP. 2005. Applications of autofluorescent proteins for in situ studies in microbial ecology. Annu. Rev. Microbiol. 59:257-277. http://dx.doi.org/10.1146/annurev.micro.59.030804.121350.
33. Coombes JL, Robey EA. 2010. Dynamic imaging of host-pathogen interactions in vivo. Nat. Rev. Immunol. 10:353-364. http://dx.doi.org/10.1038/nri2746.
34. Konjufca V, Miller MJ. 2009. Two-photon microscopy of host-pathogen interactions: acquiring a dynamic picture of infection in vivo. Cell. Microbiol. 11:551-559. http://dx.doi.org/10.1111/j.1462-5822.2009.01289.x.
35. Campisi L, Brau F, Glaichenhaus N. 2008. Imaging host-pathogen interactions. Immunol. Rev. 221:188-199. http://dx.doi.org/10.1111/j.1600-065X.2008.00586.x.
36. Bumann D, Valdivia RH. 2007. Identification of host-induced pathogen genes by differential fluorescence induction reporter systems. Nat. Protoc. 2:770-777. http://dx.doi.org/10.1038/nprot.2007.78.
37. Cronin M, Knobel M, O'Connell-Motherway M, Fitzgerald GF, van Sinderen D. 2007. Molecular dissection of a bifidobacterial replicon. Appl. Environ. Microbiol. 73:7858-7866. http://dx.doi.org/10.1128/AEM.01630-07.
38. Wickes BL, Edman JC. 1995. The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol. Microbiol. 16:1099-1109. http://dx.doi.org/10.1111/j.1365-2958.1995.tb02335.x.
39. Gleinser M, Grimm V, Zhurina D, Yuan J, Riedel CU. 2012. Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA. Microb. Cell Fact. 11:80. http://dx.doi.org/10.1186/1475-2859-11-80.
40. Neu C, Sedlag A, Bayer C, Förster S, Crauwels P, Niess J-H, van Zandbergen G, Frascaroli G, Riedel CU. 2013. CD14-dependent monocyte isolation enhances phagocytosis of Listeria monocytogenes by proinflammatory, GM-CSF-derived macrophages. PLoS One 8:e66898. http://dx.doi.org/10.1371/journal.pone.0066898.
41. Klijn A, Moine D, Delley M, Mercenier A, Arigoni F, Pridmore RD. 2006. Construction of a reporter vector for the analysis of Bifidobacterium longum promoters. Appl. Environ. Microbiol. 72:7401-7405. http://dx.doi.org/10.1128/AEM.01611-06.
42. Khokhlova EV, Efimov BA, Kafarskaia LI, Shkoporov AN. 2010. Heterologous expression of secreted biologically active human interleukin-10 in Bifidobacterium breve. Arch. Microbiol. 192:769-774. http://dx.doi.org/10.1007/s00203-010-0606-4.
43. Shkoporov AN, Efimov BA, Khokhlova EV, Kafarskaia LI, Smeianov VV. 2008. Production of human basic fibroblast growth factor (FGF-2) in Bifidobacterium breve using a series of novel expression/secretion vectors. Biotechnol. Lett. 30:1983-1988. http://dx.doi.org/10.1007/s10529-008-9772-8.
44. Zhurina D, Zomer A, Gleinser M, Brancaccio VF, Auchter M, Waidmann MS, Westermann C, van Sinderen D, Riedel CU. 2011. Complete genome sequence of Bifidobacterium bifidum S17. J. Bacteriol. 193:301-302. http://dx.doi.org/10.1128/JB.01180-10.
45. Riedel CU, Monk IR, Casey PG, Morrissey D, O'Sullivan GC, Tangney M, Hill C, Gahan CGM. 2007. Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl. Environ. Microbiol. 73:3091-3094. http://dx.doi.org/10.1128/AEM.02940-06.
46. Jensen PR, Hammer K. 1998. The sequence of spacers between the consensus sequences modulates the strength of prokaryotic promoters. Appl. Environ. Microbiol. 64:82-87.
47. Balestrino D, Hamon MA, Dortet L, Nahori M-A, Pizarro-Cerda J, Alignani D, Dussurget O, Cossart P, Toledo-Arana A. 2010. Single-cell techniques using chromosomally tagged fluorescent bacteria to study Listeria monocytogenes infection processes. Appl. Environ. Microbiol. 76: 3625-3636. http://dx.doi.org/10.1128/AEM.02612-09.
48. Riedel CU, Casey PG, Mulcahy H, O'Gara F, Gahan CGM, Hill C. 2007. Construction of p16Slux, a novel vector for improved bioluminescent labeling of Gram-negative bacteria. Appl. Environ. Microbiol. 73:7092-7095. http://dx.doi.org/10.1128/AEM.01394-07.
49. Shen A, Higgins DE. 2005. The 5= untranslated region-mediated enhancement of intracellular listeriolysin O production is required for Listeria monocytogenes pathogenicity. Mol. Microbiol. 57:1460-1473. http://dx.doi.org/10.1111/j.1365-2958.2005.04780.x.
50. Berger B, Moine D, Mansourian R, Arigoni F. 2010. HspR mutations are naturally selected in Bifidobacterium longum when successive heat shock treatments are applied. J. Bacteriol. 192:256-263. http://dx.doi.org/10.1128/JB.01147-09.
51. Ruiz L, Alvarez-Martín P, Mayo B, de Los Reyes-Gavilán CG, Gueimonde M, Margolles A. 2012. Controlled gene expression in bifidobacteria by use of a bile-responsive element. Appl. Environ. Microbiol. 78: 581-585. http://dx.doi.org/10.1128/AEM.06611-11.
52. Rossi M, Brigidi P, Matteuzzi D. 1998. Improved cloning vectors for Bifidobacterium spp. Lett. Appl. Microbiol. 26:101-104. http://dx.doi.org/10.1046/j.1472-765X.1998.00285.x.
53. González-Rodríguez I, Ruiz L, Gueimonde M, Margolles A, Sánchez B. 2013. Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract. FEMS Microbiol. Lett. 340:1-10. http://dx.doi.org/10.1111/1574-6968.12056.
54. Laparra JM, Sanz Y. 2009. Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Lett. Appl. Microbiol. 49:695-701. http://dx.doi.org/10.1111/j.1472-765X.2009.02729.x.
55. Tuomola EM, Salminen SJ. 1998. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int. J. Food Microbiol. 41:45-51. http://dx.doi.org/10.1016/S0168-1605(98)00033-6.
56. Vélez MP, De Keersmaecker SCJ, Vanderleyden J. 2007. Adherence factors of Lactobacillus in the human gastrointestinal tract. FEMS Microbiol. Lett. 276:140-148. http://dx.doi.org/10.1111/j.1574-6968.2007.00908.x.
57. Bernet MF, Brassart D, Neeser JR, Servin AL. 1993. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol. 59:4121-4128.
58. Riedel CU, Foata F, Goldstein DR, Blum S, Eikmanns BJ. 2006. Interaction of bifidobacteria with Caco-2 cells-adhesion and impact on expression profiles. Int. J. Food Microbiol. 110:62-68. http://dx.doi.org/10.1016/j.ijfoodmicro.2006.01.040.
59. Vesterlund S, Paltta J, Karp M, Ouwehand AC. 2005. Measurement of bacterial adhesion-in vitro evaluation of different methods. J. Microbiol. Methods 60:225-233. http://dx.doi.org/10.1016/j.mimet.2004.09.013.
60. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker H-C. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-258. http://dx.doi.org/10.1126/science.1102901.
61. Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, Niess JH. 2013. CX(3)CR1(+) macrophages support IL-22 production by in-nate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 6:177-188. http://dx.doi.org/10.1038/mi.2012.61.
62. Rossini V, Zhurina D, Radulovic K, Manta C, Walther P, Riedel CU, Niess JH. 16 October 2013. CX3CR1(+) cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis. Mucosal Immunol. http://dx.doi.org/10.1038/mi.2013.70.
63. Nikitas G, Deschamps C, Disson O, Niault T, Cossart P, Lecuit M. 2011. Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J. Exp. Med. 208: 2263-2277. http://dx.doi.org/10.1084/jem.20110560.
64. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-367. http://dx.doi.org/10.1038/86373.
65. Zhao M, Yang M, Baranov E, Wang X, Penman S, Moossa AR, Hoffman RM. 2001. Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Proc. Natl. Acad. Sci. U. S. A. 98:9814-9818. http://dx.doi.org/10.1073/pnas.161275798.
66. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. 2007. Monotherapy with a tumor-targeting mutant of Salmonella Typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 104:10170-10174. http://dx.doi.org/10.1073/pnas.0703867104.
67. Zhao M, Yang M, Li X-M, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM. 2005. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella Typhimurium. Proc. Natl. Acad. Sci. U. S. A. 102:755-760. http://dx.doi.org/10.1073/pnas.0408422102.
68. Mehta SR, Huang R, Yang M, Zhang X-Q, Kolli B, Chang K-P, Hoffman RM, Goto Y, Badaro R, Schooley RT. 2008. Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery. Clin. Vaccine Immunol. 15: 1764-1770. http://dx.doi.org/10.1128/CVI.00270-08.
69. Andreu N, Zelmer A, Wiles S. 2011. Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol. Rev. 35:360-394. http://dx.doi.org/10.1111/j.1574-6976.2010.00252.x.